drugset / Trial / NCT02606539

Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms

NCT02606539

Phase 2/3 Unknown 20 enrolled Maher elesawi kamel elesawi
RandomizedParallel-groupSingle-blindTreatment

Summary

Gestational trophoblastic neoplasm affect women and is sensitive to chemotherapy especially methotrexate and the investigators try to find a role of surgery plus methotrexate instead of multiple doses and cycles of chemotherapy.

Timeline

Start
2015-09
Primary completion
2017-06
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule 1 mg/kg Intramuscular
Comparator Leucovorin Small molecule 0.1 mg/kg